PDB Short entry for 5A37 HEADER ACTIN-BINDING PROTEIN 27-MAY-15 5A37 TITLE MUTATIONS IN THE CALPONIN HOMOLOGY DOMAIN OF ALPHA-ACTININ-2 TITLE 2 AFFECT ACTIN BINDING AND INCORPORATION IN MUSCLE. COMPND MOL_ID: 1; COMPND 2 MOLECULE: HUMAN ALPHA-ACTININ-2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CALPONIN HOMOLOGY DOMAIN; COMPND 5 SYNONYM: ALPHA-ACTININ SKELETAL MUSCLE ISOFORM 2, F-ACTIN COMPND 6 CROSS-LINK ING PROTEIN, HUMAN ALPHA-ACTININ-2; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 OTHER_DETAILS: DOMAIN CONTAINING RESIDUES 19 TO 266. POINT MUTATION COMPND 10 G111V AT POSITION 111 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PGEX-6P-1 KEYWDS ACTIN-BINDING PROTEIN, HUMAN ALPHA-ACTININ-2, CALPONIN HOMOLOGY KEYWDS 2 DOMAINS EXPDTA X-RAY DIFFRACTION AUTHOR N.J.HAYWOOD,M.WOLNY,C.H.TRINH,Y.SHUPING,T.A.EDWARDS,M.PECKHAM REVDAT 2 24-AUG-16 5A37 1 JRNL REVDAT 1 22-JUN-16 5A37 0 JRNL AUTH N.HAYWOOD,M.WOLNY,B.ROGERS,C.H.TRINH,Y.SHUPING,T.A.EDWARDS, JRNL AUTH 2 M.PECKHAM JRNL TITL HYPERTROPHIC CARDIOMYOPATHY MUTATIONS IN THE CALPONIN- JRNL TITL 2 HOMOLOGY DOMAIN OF ACTN2 AFFECT ACTIN BINDING AND JRNL TITL 3 CARDIOMYOCYTE Z-DISC INCORPORATION. JRNL REF BIOCHEM.J. V. 473 2485 2016 JRNL REFN ISSN 0264-6021 JRNL PMID 27287556 JRNL DOI 10.1042/BCJ20160421 REMARK 2 REMARK 2 RESOLUTION. 1.88 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0049 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU, REMARK 3 STEINER,NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.88 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 67.14 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 94.18 REMARK 3 NUMBER OF REFLECTIONS : 32847 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.17979 REMARK 3 R VALUE (WORKING SET) : 0.17788 REMARK 3 FREE R VALUE : 0.21586 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.0 REMARK 3 FREE R VALUE TEST SET COUNT : 1738 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.875 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.924 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2277 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 87.70 REMARK 3 BIN R VALUE (WORKING SET) : 0.275 REMARK 3 BIN FREE R VALUE SET COUNT : 111 REMARK 3 BIN FREE R VALUE : 0.376 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3547 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 307 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.808 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.23 REMARK 3 B22 (A**2) : 0.92 REMARK 3 B33 (A**2) : -0.27 REMARK 3 B12 (A**2) : 0.04 REMARK 3 B13 (A**2) : 0.08 REMARK 3 B23 (A**2) : 0.91 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.162 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.144 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.097 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.308 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.954 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.934 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3610 ; 0.007 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3547 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4876 ; 1.147 ; 1.953 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8160 ; 0.777 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 439 ; 4.837 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 167 ;36.314 ;24.371 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 675 ;11.945 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 23 ;12.897 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 543 ; 0.066 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4012 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 815 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1756 ; 1.015 ; 1.958 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1755 ; 1.009 ; 1.957 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2189 ; 1.728 ; 2.925 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1854 ; 1.309 ; 2.130 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. REMARK 4 REMARK 4 5A37 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-MAY-15. REMARK 100 THE PDBE ID CODE IS EBI-63162. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-DEC-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9464 REMARK 200 MONOCHROMATOR : SI (111) DOUBLE CRYSTAL REMARK 200 MONOCHROMATOR REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL (PILATUS 6M-F) REMARK 200 DETECTOR MANUFACTURER : DECTRIS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34585 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.90 REMARK 200 RESOLUTION RANGE LOW (A) : 43.60 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.2 REMARK 200 DATA REDUNDANCY : 2.1 REMARK 200 R MERGE (I) : 0.08 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.60 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.88 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.98 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.1 REMARK 200 DATA REDUNDANCY IN SHELL : 2.1 REMARK 200 R MERGE FOR SHELL (I) : 0.41 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.00 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC5 REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 28% POLYETHYLENE GLYCOL 2000 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 17 REMARK 465 PRO A 18 REMARK 465 TYR A 19 REMARK 465 MET A 20 REMARK 465 ILE A 21 REMARK 465 GLN A 22 REMARK 465 GLU A 23 REMARK 465 GLU A 24 REMARK 465 GLU A 25 REMARK 465 TRP A 26 REMARK 465 ASP A 27 REMARK 465 ARG A 28 REMARK 465 ASP A 29 REMARK 465 LEU A 30 REMARK 465 LEU A 31 REMARK 465 LEU A 32 REMARK 465 ASP A 33 REMARK 465 LYS A 113 REMARK 465 LEU A 114 REMARK 465 VAL A 115 REMARK 465 SER A 116 REMARK 465 GLY A 258 REMARK 465 ALA A 259 REMARK 465 GLU A 260 REMARK 465 GLN A 261 REMARK 465 ALA A 262 REMARK 465 GLU A 263 REMARK 465 THR A 264 REMARK 465 ALA A 265 REMARK 465 ALA A 266 REMARK 465 GLY B 17 REMARK 465 PRO B 18 REMARK 465 TYR B 19 REMARK 465 MET B 20 REMARK 465 ILE B 21 REMARK 465 GLN B 22 REMARK 465 GLU B 23 REMARK 465 GLU B 24 REMARK 465 GLU B 25 REMARK 465 TRP B 26 REMARK 465 ASP B 27 REMARK 465 ARG B 28 REMARK 465 ASP B 29 REMARK 465 LEU B 30 REMARK 465 LEU B 31 REMARK 465 LEU B 32 REMARK 465 ASP B 33 REMARK 465 PRO B 34 REMARK 465 LYS B 113 REMARK 465 LEU B 114 REMARK 465 VAL B 115 REMARK 465 SER B 116 REMARK 465 GLY B 258 REMARK 465 ALA B 259 REMARK 465 GLU B 260 REMARK 465 GLN B 261 REMARK 465 ALA B 262 REMARK 465 GLU B 263 REMARK 465 THR B 264 REMARK 465 ALA B 265 REMARK 465 ALA B 266 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 60 -50.53 -125.06 REMARK 500 ALA A 153 -139.12 61.58 REMARK 500 HIS A 177 -85.88 -140.92 REMARK 500 ALA B 153 -141.67 62.78 REMARK 500 HIS B 177 -88.70 -143.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5A36 RELATED DB: PDB REMARK 900 MUTATIONS IN THE CALPONIN HOMOLOGY DOMAIN OF ALPHA- REMARK 900 ACTININ-2 AFFECT ACTIN BINDING AND INCORPORATION IN REMARK 900 MUSCLE. REMARK 900 RELATED ID: 5A38 RELATED DB: PDB REMARK 900 MUTATIONS IN THE CALPONIN HOMOLOGY DOMAIN OF ALPHA- REMARK 900 ACTININ-2 AFFECT ACTIN BINDING AND INCORPORATION IN REMARK 900 MUSCLE. DBREF 5A37 A 19 266 UNP P35609 ACTN2_HUMAN 19 266 DBREF 5A37 B 19 266 UNP P35609 ACTN2_HUMAN 19 266 SEQADV 5A37 GLY A 17 UNP P35609 EXPRESSION TAG SEQADV 5A37 PRO A 18 UNP P35609 EXPRESSION TAG SEQADV 5A37 VAL A 111 UNP P35609 GLY 111 ENGINEERED MUTATION SEQADV 5A37 GLY B 17 UNP P35609 EXPRESSION TAG SEQADV 5A37 PRO B 18 UNP P35609 EXPRESSION TAG SEQADV 5A37 VAL B 111 UNP P35609 GLY 111 ENGINEERED MUTATION SEQRES 1 A 250 GLY PRO TYR MET ILE GLN GLU GLU GLU TRP ASP ARG ASP SEQRES 2 A 250 LEU LEU LEU ASP PRO ALA TRP GLU LYS GLN GLN ARG LYS SEQRES 3 A 250 THR PHE THR ALA TRP CYS ASN SER HIS LEU ARG LYS ALA SEQRES 4 A 250 GLY THR GLN ILE GLU ASN ILE GLU GLU ASP PHE ARG ASN SEQRES 5 A 250 GLY LEU LYS LEU MET LEU LEU LEU GLU VAL ILE SER GLY SEQRES 6 A 250 GLU ARG LEU PRO LYS PRO ASP ARG GLY LYS MET ARG PHE SEQRES 7 A 250 HIS LYS ILE ALA ASN VAL ASN LYS ALA LEU ASP TYR ILE SEQRES 8 A 250 ALA SER LYS VAL VAL LYS LEU VAL SER ILE GLY ALA GLU SEQRES 9 A 250 GLU ILE VAL ASP GLY ASN VAL LYS MET THR LEU GLY MET SEQRES 10 A 250 ILE TRP THR ILE ILE LEU ARG PHE ALA ILE GLN ASP ILE SEQRES 11 A 250 SER VAL GLU GLU THR SER ALA LYS GLU GLY LEU LEU LEU SEQRES 12 A 250 TRP CYS GLN ARG LYS THR ALA PRO TYR ARG ASN VAL ASN SEQRES 13 A 250 ILE GLN ASN PHE HIS THR SER TRP LYS ASP GLY LEU GLY SEQRES 14 A 250 LEU CYS ALA LEU ILE HIS ARG HIS ARG PRO ASP LEU ILE SEQRES 15 A 250 ASP TYR SER LYS LEU ASN LYS ASP ASP PRO ILE GLY ASN SEQRES 16 A 250 ILE ASN LEU ALA MET GLU ILE ALA GLU LYS HIS LEU ASP SEQRES 17 A 250 ILE PRO LYS MET LEU ASP ALA GLU ASP ILE VAL ASN THR SEQRES 18 A 250 PRO LYS PRO ASP GLU ARG ALA ILE MET THR TYR VAL SER SEQRES 19 A 250 CYS PHE TYR HIS ALA PHE ALA GLY ALA GLU GLN ALA GLU SEQRES 20 A 250 THR ALA ALA SEQRES 1 B 250 GLY PRO TYR MET ILE GLN GLU GLU GLU TRP ASP ARG ASP SEQRES 2 B 250 LEU LEU LEU ASP PRO ALA TRP GLU LYS GLN GLN ARG LYS SEQRES 3 B 250 THR PHE THR ALA TRP CYS ASN SER HIS LEU ARG LYS ALA SEQRES 4 B 250 GLY THR GLN ILE GLU ASN ILE GLU GLU ASP PHE ARG ASN SEQRES 5 B 250 GLY LEU LYS LEU MET LEU LEU LEU GLU VAL ILE SER GLY SEQRES 6 B 250 GLU ARG LEU PRO LYS PRO ASP ARG GLY LYS MET ARG PHE SEQRES 7 B 250 HIS LYS ILE ALA ASN VAL ASN LYS ALA LEU ASP TYR ILE SEQRES 8 B 250 ALA SER LYS VAL VAL LYS LEU VAL SER ILE GLY ALA GLU SEQRES 9 B 250 GLU ILE VAL ASP GLY ASN VAL LYS MET THR LEU GLY MET SEQRES 10 B 250 ILE TRP THR ILE ILE LEU ARG PHE ALA ILE GLN ASP ILE SEQRES 11 B 250 SER VAL GLU GLU THR SER ALA LYS GLU GLY LEU LEU LEU SEQRES 12 B 250 TRP CYS GLN ARG LYS THR ALA PRO TYR ARG ASN VAL ASN SEQRES 13 B 250 ILE GLN ASN PHE HIS THR SER TRP LYS ASP GLY LEU GLY SEQRES 14 B 250 LEU CYS ALA LEU ILE HIS ARG HIS ARG PRO ASP LEU ILE SEQRES 15 B 250 ASP TYR SER LYS LEU ASN LYS ASP ASP PRO ILE GLY ASN SEQRES 16 B 250 ILE ASN LEU ALA MET GLU ILE ALA GLU LYS HIS LEU ASP SEQRES 17 B 250 ILE PRO LYS MET LEU ASP ALA GLU ASP ILE VAL ASN THR SEQRES 18 B 250 PRO LYS PRO ASP GLU ARG ALA ILE MET THR TYR VAL SER SEQRES 19 B 250 CYS PHE TYR HIS ALA PHE ALA GLY ALA GLU GLN ALA GLU SEQRES 20 B 250 THR ALA ALA FORMUL 3 HOH *307(H2 O) HELIX 1 1 ALA A 35 ARG A 53 1 19 HELIX 2 2 LYS A 54 GLY A 56 5 3 HELIX 3 3 GLY A 69 GLY A 81 1 13 HELIX 4 4 MET A 92 VAL A 111 1 20 HELIX 5 5 GLY A 118 ASP A 124 1 7 HELIX 6 6 ASN A 126 ILE A 143 1 18 HELIX 7 7 ALA A 153 THR A 165 1 13 HELIX 8 8 HIS A 177 LYS A 181 5 5 HELIX 9 9 GLY A 183 ARG A 194 1 12 HELIX 10 10 PRO A 195 ILE A 198 5 4 HELIX 11 11 ASP A 199 LEU A 203 5 5 HELIX 12 12 ASP A 207 ASP A 224 1 18 HELIX 13 13 ASP A 230 THR A 237 1 8 HELIX 14 14 ASP A 241 ALA A 257 1 17 HELIX 15 15 ALA B 35 ARG B 53 1 19 HELIX 16 16 LYS B 54 GLY B 56 5 3 HELIX 17 17 ASN B 61 PHE B 66 1 6 HELIX 18 18 GLY B 69 GLY B 81 1 13 HELIX 19 19 MET B 92 VAL B 111 1 20 HELIX 20 20 GLY B 118 ASP B 124 1 7 HELIX 21 21 ASN B 126 ILE B 143 1 18 HELIX 22 22 ALA B 153 ALA B 166 1 14 HELIX 23 23 HIS B 177 LYS B 181 5 5 HELIX 24 24 GLY B 183 ARG B 194 1 12 HELIX 25 25 PRO B 195 ILE B 198 5 4 HELIX 26 26 ASP B 199 LEU B 203 5 5 HELIX 27 27 ASP B 207 ASP B 224 1 18 HELIX 28 28 ASP B 230 ASN B 236 1 7 HELIX 29 29 ASP B 241 PHE B 256 1 16 SHEET 1 AA 2 SER A 147 VAL A 148 0 SHEET 2 AA 2 THR A 151 SER A 152 -1 O THR A 151 N VAL A 148 SHEET 1 BA 2 SER B 147 VAL B 148 0 SHEET 2 BA 2 THR B 151 SER B 152 -1 O THR B 151 N VAL B 148 CRYST1 38.240 46.490 70.380 73.68 80.08 75.53 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026151 -0.006748 -0.002984 0.00000 SCALE2 0.000000 0.022215 -0.005723 0.00000 SCALE3 0.000000 0.000000 0.014895 0.00000